Navigation Links
GDS International Leads the Way for the Pharmaceutical Industry at its Upcoming NGP DD 30 Summit in Madrid
Date:6/12/2013

MADRID, June 12, 2013 /PRNewswire/ --

On 9th - 11th September, a selection of the region's most prominent C-level executives from across the pharmaceutical industry will convene at the Sheraton Mirasierra Hotel & Spa, Madrid at GDS International's fifth European Next Generation Pharmaceutical Drug Discovery Summit.

This year NGP DD 30 has elected 30 of the most well-respected decision makers from the pharmaceutical sector to meet, network, and assess the rapidly evolving industry in a vibrant, closed door environment at the 2.5 day event.

The exclusive location, the intimate number of delegates and the outstanding content offer the executives an ideal structure for new business relationships to grow. The series of interactive workshops and moderated peer-led panel discussions give delegates the opportunity to meet with business analysts and solution providers to determine strategies and solutions for the year ahead.

Included within this year's delegation are Sibo de Jong, Vice-President Pharmaceutical R&D, Astellas; Simon Read, Vice President & Head of Global Biomedical Sciences, Andreas Schneider, VP Life Science Alliances, Roche; Michael Rotte, Biomarker Development EU Head, Novartis; Dave Gunput, Head of Translational Medicine & Exploratory Development, Mitsubishi Pharmaceutical.

The industry is facing its biggest ever challenges. With the help of all involved the summit will highlight the most relevant areas in today's market. Topics to be discussed at this year's summit include; Personalizing Medicine, Slip Streaming the R&D Process & Reducing Late Stage Attrition.

Bjorn Mellgard, Global Head of Translational Medicine Gastrointestinal, Novartis attended last year's summit, and said: 'The quality of the discussions and the quality of the attendees has been really valuable. Highly relevant topics and overall, above my expectations" he added, "it was a really worthwhile investment - it's really been good to be here".

The summit aims to provide the perfect environment for key decision makers to network and collaborate with their peers, discuss organizational strategies for the future and establish meaningful working relationships with a dynamic selection of delegates, vendors and sponsors. Offering an alternative to the traditional conference format, the summits provide true innovation and value for money.

Charlotte Wright, Summit Director at GDS International, the global business event company behind NGP DD, says, "The Industry and Academia need to work alongside each other and become more open with the sharing of information if this Industry is to move forward, which I feel is where the Next Generation Pharmaceutical Drug Development 30 (NGP DD 30) comes into play. The NGP DD 30 summit brings together 30 Senior Level executives from within the Industry to network and mind share with their peers. We offer our executives an exciting opportunity to dissect the industry, share personal experiences and come up with best practices moving forward. I for one thoroughly look forward to the discussions and seeing the outcomes at the event in September. No doubt this will once again be a fantastic event!"

For more information, please visit http://www.pharmasummiteurope.com

About GDS International

GDS International creates engagement opportunities for business, onsite and online. We bring senior executives together, face-to-face, at exclusive summits, conferences, and on virtual private roundtables to advance their business with brilliant results. We create tangible business opportunities: networking platforms that help to establish thought leaders, stay in touch with existing partners, and stay abreast of crucial market, technology and regulatory developments. We're almost 20 years old. Our headquarters are based in Bristol, UK, with subsidiaries offices in New York, Miami and Sydney. 

For more information about GDS International or any of its many products please visit http://www.gdsinternational.com 

Contact & press partnerships information:
Charlie Bestall, Summit Marketing Manager
charlie.bestall @gdsinternational.com
+44-(0)117-921-2754


'/>"/>
SOURCE GDS International
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RSB Spine, LLC, Announces International Distribution and Licensing Agreement
2. PAREXEL International To Present At William Blair Growth Stock Conference And Goldman Sachs Healthcare Conference
3. MEDIFIRST SOLUTIONS, INC. To Exhibit At The Orlando International Beauty Show
4. DMH International Announces EMR Integration to TouchPACS
5. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
6. Israel Brain Technologies Announces Israels 1st International Brain Technology Conference
7. Clinical Team Researching the Impact of the EarlySense System Wins Best Novel Idea Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
8. PAREXEL International To Present At Jefferies Healthcare Conference
9. Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
10. IsoRay Announces A New International Distributor For Greece
11. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ... May 21, 2020 , ... ... needs in the field of urology, today announced that Naveen Divakaruni, D.O., Advocate ... Excellence. The designation recognizes that Dr. Divakaruni has achieved a high level of ...
(Date:5/21/2020)... ... ... Labyrinthe Labs has announced the launch of its brand new and ground-breaking ... for fast-action relief of joint and muscle soreness, Lefa is botanically powered by a ... and muscles. , According to the National Institutes of Health , approximately ...
(Date:5/17/2020)... ... 2020 , ... The Sea Cucumber-derived triterpenoid glycoside Frondoside A, which has been ... the Sea Cucumber in a proprietary process to give SeaCare Dietary Supplement ... and time again: “You get what you pay for.” It is usually in reference ...
Breaking Medicine Technology:
(Date:5/27/2020)... LAUREL, N.J. (PRWEB) , ... May 27, 2020 ... ... contract manufacturer, announces that it is now manufacturing face shields to be ... novel coronavirus that causes COVID-19. These face shields are single use, made to ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... of Washington Professor of Bioengineering, Founder & Editor of scientific journal WATER, ... ( https://www.amazon.com/Fourth-Phase-Water-Beyond-Liquid-ebook/dp/B00N2ASKF2 ) , https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water , * , During ...
(Date:5/26/2020)... ... , ... Today TRC Companies (“ TRC ”) announced the release of its ... owners and leaders assess whether their organizations are prepared to move forward as the ... intended to assist business leaders evaluate their readiness relative to CDC guidance and provides ...
(Date:5/25/2020)... ... ... Winemaker Grant Long Jr. is introducing three Toilet Paper Reserve wines. “These are ... complicated times,” he said, in announcing the new wines. The wines are 2019 Chardonnay ... Wine Blend are sourced in the Napa Valley; the Grenache comes from the El ...
(Date:5/21/2020)... Minn. (PRWEB) , ... May 21, 2020 , ... ... medical device manufacturer, announces its first milestone to deliver over one million FDA-compliant ... eight weeks. Summit Medical Face Shields meet the critical need for personal protective ...
Breaking Medicine News(10 mins):